ArticleFrontiers in cardiovascular medicine2026
Magnetocardiography in the diagnosis of suspected ANOCA: a case series.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with angina pectoris with non-obstructive coronary artery disease (ANOCA) often present to cardiology outpatient clinic or emergency departments with manifestations mimicking acute coronary syndrome (ACS). As a working diagnosis defined by angina pectoris in the absence of obstructive coronary arteries, ANOCA requires a stepwise diagnostic process-one that incorporates coronary functional assessments and provocative tests. Magnetocardiography (MCG) is a diagnostic modality with the potential to distinguish mild myocardial ischemic in patients with suspected ANOCA from nonischemic cardiac presentations, thereby shortening the diagnostic timeline and optimizing the clinical workflow. Three patients with angina pectoris and non-obstructive coronary arteries on CCTA were referred for MCG evaluation. We evaluated ischemic features on MCG waveforms. Notably, even in cases where ischemia could not be identified via electrocardiography (ECG), the ischemic features on MCG waveforms remained highly prominent. This study describes the clinical and MCG features of patients with suspected ANOCA, explores MCG's utility for diagnosing coronary microvascular dysfunction (CMD), and informs future research. The application potential of MCG in cardiology-specifically for the evaluation of acute chest pain-has recently garnered significant attention. To our knowledge, prior investigations in the context of ANOCA or CMD have not focused on the systematic characterization of specific MCG waveform patterns. Our documentation of positive MCG findings in these patients presenting with suspected ACS but having non-obstructive arteries supports MCG's potential in detecting subtle ischemia and optimizing clinical workflow.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.